EFTA01521293.pdf

GHISLAINE MAXWELL ACCT For the Period 711/12 to 7/31/12 Account Summary Beginning Ending Change Estimated Current Asset Allocation Asset Allocation Market Value Market Value In Value Annual Income Allocation Equity 699,453.63 702,849.78 3,396.15 45,693.48 10% Alternative Assets 73,807.67 74,867.63 1,059.96 1% Other Cash 8 Fixed Income 7,279,499.92 7,310,742.47 31,242.55 49,399.13 88% Other 88 527.17 91 365.48 2.83831 1% AlfaMaw Assay Market Value $8.141,288.38 $8,178,826.36 539,636.97 996,092.61 100% Equity Accruals 20,140 41 1339508 (6 745 33) Market Value with Accruals 58,161,428.80 $8,193,220.44 $31.791.64 Cash Find Income Current Year-to-Cate Portfolio Activity Period Value Value Beginning Market Value 8,141,288.39 4.926.904.29 Contributions 4.972.947 20 VVithdrawals & Fees (201.35) (2,080,496.26) Secunties Transferred In 1,263,208.64 10,437,467.27 Securities Transferred Out 1 261 872.26 10 332 905.21 Net ContrlbutlonslWithdrawals 81,135.03 22,997,013.00 Income 8. Distributions 19,025.53 66,703.43 Change In Investment Value 18.376.41 189.204 64 Ending Market Value 38.178,826.38 58,179,826.36 Accruals 13,395.08 13.395 08 Market Value with Accruals $8,193,220.44 58.193.220.44 JP Morgan Page 2 of 31 Confidential Treatment Requested by JPMorgan JPM-SDNY-00048667 Chase CONFIDENTIAL SDNY_GM_00317865 EFTA01521293